RANI
Price
$1.40
Change
-$0.02 (-1.41%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
136.57M
69 days until earnings call
Intraday BUY SELL Signals
VNDA
Price
$7.70
Change
+$0.26 (+3.49%)
Updated
Jan 14 closing price
Capitalization
455.64M
27 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RANI vs VNDA

Header iconRANI vs VNDA Comparison
Open Charts RANI vs VNDABanner chart's image
Rani Therapeutics Holdings
Price$1.40
Change-$0.02 (-1.41%)
Volume$5.78K
Capitalization136.57M
Vanda Pharmaceuticals
Price$7.70
Change+$0.26 (+3.49%)
Volume$905.42K
Capitalization455.64M
RANI vs VNDA Comparison Chart in %
RANI
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RANI vs. VNDA commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RANI is a Hold and VNDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (RANI: $1.40 vs. VNDA: $7.70)
Brand notoriety: RANI and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RANI: 45% vs. VNDA: 45%
Market capitalization -- RANI: $136.57M vs. VNDA: $455.64M
RANI [@Biotechnology] is valued at $136.57M. VNDA’s [@Biotechnology] market capitalization is $455.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RANI’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • RANI’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both RANI and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RANI’s TA Score shows that 5 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • RANI’s TA Score: 5 bullish, 4 bearish.
  • VNDA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RANI is a better buy in the short-term than VNDA.

Price Growth

RANI (@Biotechnology) experienced а +0.72% price change this week, while VNDA (@Biotechnology) price change was -9.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

RANI is expected to report earnings on Mar 25, 2026.

VNDA is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($456M) has a higher market cap than RANI($137M). RANI YTD gains are higher at: 5.185 vs. VNDA (-12.698). RANI has higher annual earnings (EBITDA): -42.95M vs. VNDA (-113.07M). VNDA has more cash in the bank: 294M vs. RANI (4.14M). VNDA has less debt than RANI: VNDA (10.9M) vs RANI (17.6M). VNDA has higher revenues than RANI: VNDA (212M) vs RANI (1.2M).
RANIVNDARANI / VNDA
Capitalization137M456M30%
EBITDA-42.95M-113.07M38%
Gain YTD5.185-12.698-41%
P/E RatioN/A126.00-
Revenue1.2M212M1%
Total Cash4.14M294M1%
Total Debt17.6M10.9M161%
FUNDAMENTALS RATINGS
VNDA: Fundamental Ratings
VNDA
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RANIVNDA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 2 days ago
69%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 6 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
RANI
Daily Signal:
Gain/Loss:
VNDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AUENX17.940.06
+0.34%
AQR Large Cap Defensive Style N
SIECX13.550.02
+0.15%
Saratoga International Equity C
MAGCX30.95-0.03
-0.10%
BlackRock Advantage Global Institutional
IJPTX13.74-0.02
-0.15%
VY® JPMorgan Emerging Markets Equity S2
PRJDX38.33-0.48
-1.24%
PGIM Jennison Global Opportunities R4

RANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with KZR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-4.70%
KZR - RANI
55%
Loosely correlated
+1.14%
IRON - RANI
40%
Loosely correlated
-4.53%
ARTV - RANI
40%
Loosely correlated
-5.74%
ACHV - RANI
33%
Loosely correlated
-2.47%
VYGR - RANI
32%
Poorly correlated
+3.08%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IVF. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+3.49%
IVF - VNDA
40%
Loosely correlated
+1.01%
VCYT - VNDA
36%
Loosely correlated
-1.39%
OLMA - VNDA
35%
Loosely correlated
+3.16%
RANI - VNDA
34%
Loosely correlated
-1.41%
APLS - VNDA
33%
Loosely correlated
-4.69%
More